Quantinno Capital Management LP Acquires 1,914 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Quantinno Capital Management LP lifted its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 32.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,846 shares of the biotechnology company’s stock after purchasing an additional 1,914 shares during the quarter. Quantinno Capital Management LP’s holdings in Axon Enterprise were worth $3,135,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the business. Menard Financial Group LLC lifted its position in Axon Enterprise by 0.8% during the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock worth $1,204,000 after buying an additional 24 shares in the last quarter. PFG Investments LLC raised its holdings in Axon Enterprise by 0.6% during the third quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock worth $1,547,000 after acquiring an additional 25 shares in the last quarter. Gladstone Institutional Advisory LLC raised its holdings in Axon Enterprise by 1.6% during the third quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock worth $656,000 after acquiring an additional 26 shares in the last quarter. Mather Group LLC. boosted its position in Axon Enterprise by 3.7% during the third quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock valued at $303,000 after purchasing an additional 27 shares during the last quarter. Finally, King Luther Capital Management Corp grew its stake in Axon Enterprise by 0.3% in the third quarter. King Luther Capital Management Corp now owns 10,474 shares of the biotechnology company’s stock valued at $4,185,000 after purchasing an additional 34 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on AXON. JMP Securities upped their price objective on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research note on Thursday, October 31st. Needham & Company LLC upped their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Robert W. Baird upped their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday. Finally, Northland Securities lifted their price target on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. One research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $488.67.

Axon Enterprise Stock Performance

NASDAQ:AXON opened at $642.59 on Tuesday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock has a 50 day simple moving average of $521.10 and a 200 day simple moving average of $396.32. Axon Enterprise, Inc. has a 1-year low of $235.33 and a 1-year high of $698.67. The stock has a market cap of $49.00 billion, a P/E ratio of 166.04, a PEG ratio of 15.13 and a beta of 1.01.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, Director Julie A. Cullivan sold 1,261 shares of Axon Enterprise stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the sale, the director now owns 2,392 shares in the company, valued at $1,631,487.52. The trade was a 34.52 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Patrick W. Smith sold 47,314 shares of the stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $400.07, for a total transaction of $18,928,911.98. Following the transaction, the chief executive officer now owns 2,983,802 shares in the company, valued at approximately $1,193,729,666.14. The trade was a 1.56 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 103,928 shares of company stock valued at $50,820,792. 5.70% of the stock is currently owned by corporate insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.